Disruption Labs

Disruption Labs is a research, development, and manufacturing firm specializing in pharmaceutical-grade nano-bioengineering applied to consumer products. The company has developed a proprietary nanotechnology platform that utilizes liposomes to enhance the solubility, stability, and bioavailability of ingredients in aqueous formulations. Its operations include laboratory services and contract manufacturing for sectors such as nutraceuticals, functional food and beverage, clinical therapeutics, and cosmetics. The firm functions as a multi-strategy solution partner, guiding products from the initial lab bench research through to scale-up and market commercialization.

This technology is critical for partners looking to overcome systemic formulation challenges, such as improving the absorption of historically difficult ingredients. By addressing issues like bioavailability and sensory profile, Disruption Labs enables businesses to create bio-enhanced products that function more effectively for consumers. The company brings its intellectual property to market through its internal CDMO, Santé Laboratories, and its consumer-facing wellness brand, RESET Bioscience, which provides scientifically validated products designed to support holistic health and stress management.